Company intelligence / Profile preview

W. R. Grace

Columbia, Maryland, United Statesgrace.com ↗

Ownership: Private
Employees: ~6000
Development stage: Other

Overview

W. R. Grace provides specialty chemicals and contract manufacturing services supporting pharmaceutical development from discovery through commercial scale-up, with expertise in silica-based chromatography resins/excipients and cGMP small molecule API/intermediate production. The company does not develop its own drugs but enables pharma/biotech companies' pipelines.

Modalities: Small molecule (custom APIs, intermediates)Chromatography resin/excipientsPeptides (peptide fragments as intermediates)Chiral intermediatesAmino acidsSilica-based materials for drug delivery
Industry: Contract Manufacturing Organization

Partnerships

Chevron (ART® Hydroprocessing Catalysts joint venture)Braskem (process technologies/catalyst solutions partnership)PetroChina Guangxi Petrochemical Company

Beyond the preview

Go deeper on W. R. Grace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on W. R. Grace.

Explore the full profile